When Seed and Soil Theory Meets Chicken or Egg Theory in Cancer Metastasis

Meenu Jain, A. Arbab, B. Achyut
{"title":"When Seed and Soil Theory Meets Chicken or Egg Theory in Cancer Metastasis","authors":"Meenu Jain, A. Arbab, B. Achyut","doi":"10.4172/2168-9652.1000e131","DOIUrl":null,"url":null,"abstract":"Cancer metastasis has been a serious problem since decades. Seed and soil hypothesis of metastasis remains true and all the metastatic tumors follow this nature’s law [1,2]. Advance metastasis or multi-organ metastasis is difficult to treat due to multi-organ dysfunction. One of the major issues in metastasis is that diagnosis occurs at the advanced stages. Secondly, we have not understood the complete mechanisms so well so far due to intricate nature of metastasis. In metastasis, seed (tumor cell) migrates to the soil (distant organs, e.g. lung, liver, brain, and bone). Several experimental studies have been done that suggested the role of bone marrow derived progenitor cells [3] (e.g. CD11b+ [4] and VEGFR1+ [5] cells) in the initiation of metastasis. Several chemokines, such as SDF-1, TNF-α, TGF-β and VEGF-A influence the recruitment of different cell types to pre-metastatic sites resulting into increased expression of specific molecules in the niche like S100A8, S100A9, lysyl oxidase (LOX), fibronectin, MMP9 and MMP2 in the initiation of premetastatic niche [6,7], which are bonafide candidates of therapeutic targeting [8]. In addition, tumor induced hypoxia has been shown to promote the premetastatic niche formation by recruiting CD11b+/Ly6Cmed/Ly6G+ cells [9] and producing LOX [10]. \n \nRecently, much attention has been given to the tumor-derived exosomes or micro vesicles that carry almost every essential cellular macromolecule and has signals to polarize cells in the tumor microenvironment and create premetastatic niche in the distant organs, before the seed (tumor cell) arrives [11,12]. Exosomes derived from melanomas were shown to educate pro-metastatic progenitor cells in the bone marrow [13]. Renal-carcinoma-derived exosomes were found to promote angiogenesis in lung tumor metastases [14]. In addition, using murine mammary carcinoma demonstrated that, tumor-derived microvesicles use osteopontin to mobilize pro-angiogenic cells from the bone marrow [15]. Surprisingly, exosomes perform cell independent miRNA biogenesis to promote tumorigenesis and metastasis [16]. Firstly, tumor derived exosomes has pro-angiogenic functions that helps tumor in building required vasculature for tumor growth. For example, Yoon et al. [17] investigated pro-angiogenic role of tumor-secreted exosomes by showing Egr-1 activation in endothelial cells through ERK1/2 and JNK signaling pathways and endothelial cell migration, which was facilitated by the tumor cell derived extracellular vesicles. On the other hand, tumor derived exosomes involved in the destruction of vasculature integrity for metastasis. For example, miR-105, which is characteristically expressed and secreted by metastatic breast cancer cells, is reported as a potent regulator of tumor cell migration through targeting the tight junction protein ZO-1 via exosomes. Tumor cell secreted exosomes deliver miR-105 to the site of endothelial monolayers that efficiently destroys tight junctions and hence the integrity of barriers against metastasis [18]. \n \nAlthough exosomes have attracted much attention and are considered as a bonafide targets for cancer therapy, their roles in tumor metastasis is poorly investigated. In addition, technologies and methods to study exosomes are growing day by day. It is possible that tumor cell exosomes are delivered to the distant organs that manipulates host environment before any immune cells or chemokine. However, what initiates tumor cell migration to the distant organs, remains unclear, i.e. chicken comes first or egg and warrants further investigations.","PeriodicalId":91216,"journal":{"name":"Biochemistry & physiology","volume":"34 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2015-02-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"7","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biochemistry & physiology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4172/2168-9652.1000e131","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 7

Abstract

Cancer metastasis has been a serious problem since decades. Seed and soil hypothesis of metastasis remains true and all the metastatic tumors follow this nature’s law [1,2]. Advance metastasis or multi-organ metastasis is difficult to treat due to multi-organ dysfunction. One of the major issues in metastasis is that diagnosis occurs at the advanced stages. Secondly, we have not understood the complete mechanisms so well so far due to intricate nature of metastasis. In metastasis, seed (tumor cell) migrates to the soil (distant organs, e.g. lung, liver, brain, and bone). Several experimental studies have been done that suggested the role of bone marrow derived progenitor cells [3] (e.g. CD11b+ [4] and VEGFR1+ [5] cells) in the initiation of metastasis. Several chemokines, such as SDF-1, TNF-α, TGF-β and VEGF-A influence the recruitment of different cell types to pre-metastatic sites resulting into increased expression of specific molecules in the niche like S100A8, S100A9, lysyl oxidase (LOX), fibronectin, MMP9 and MMP2 in the initiation of premetastatic niche [6,7], which are bonafide candidates of therapeutic targeting [8]. In addition, tumor induced hypoxia has been shown to promote the premetastatic niche formation by recruiting CD11b+/Ly6Cmed/Ly6G+ cells [9] and producing LOX [10]. Recently, much attention has been given to the tumor-derived exosomes or micro vesicles that carry almost every essential cellular macromolecule and has signals to polarize cells in the tumor microenvironment and create premetastatic niche in the distant organs, before the seed (tumor cell) arrives [11,12]. Exosomes derived from melanomas were shown to educate pro-metastatic progenitor cells in the bone marrow [13]. Renal-carcinoma-derived exosomes were found to promote angiogenesis in lung tumor metastases [14]. In addition, using murine mammary carcinoma demonstrated that, tumor-derived microvesicles use osteopontin to mobilize pro-angiogenic cells from the bone marrow [15]. Surprisingly, exosomes perform cell independent miRNA biogenesis to promote tumorigenesis and metastasis [16]. Firstly, tumor derived exosomes has pro-angiogenic functions that helps tumor in building required vasculature for tumor growth. For example, Yoon et al. [17] investigated pro-angiogenic role of tumor-secreted exosomes by showing Egr-1 activation in endothelial cells through ERK1/2 and JNK signaling pathways and endothelial cell migration, which was facilitated by the tumor cell derived extracellular vesicles. On the other hand, tumor derived exosomes involved in the destruction of vasculature integrity for metastasis. For example, miR-105, which is characteristically expressed and secreted by metastatic breast cancer cells, is reported as a potent regulator of tumor cell migration through targeting the tight junction protein ZO-1 via exosomes. Tumor cell secreted exosomes deliver miR-105 to the site of endothelial monolayers that efficiently destroys tight junctions and hence the integrity of barriers against metastasis [18]. Although exosomes have attracted much attention and are considered as a bonafide targets for cancer therapy, their roles in tumor metastasis is poorly investigated. In addition, technologies and methods to study exosomes are growing day by day. It is possible that tumor cell exosomes are delivered to the distant organs that manipulates host environment before any immune cells or chemokine. However, what initiates tumor cell migration to the distant organs, remains unclear, i.e. chicken comes first or egg and warrants further investigations.
当种子和土壤理论在肿瘤转移中遇到鸡还是蛋理论
几十年来,癌症转移一直是一个严重的问题。转移的种子土壤假说仍然成立,所有的转移瘤都遵循这一自然规律[1,2]。由于多器官功能障碍,早期转移或多器官转移难以治疗。转移的一个主要问题是诊断发生在晚期。其次,由于转移的复杂性,到目前为止,我们还没有很好地了解完整的机制。在转移中,种子(肿瘤细胞)迁移到土壤(远端器官,如肺、肝、脑和骨)。一些实验研究表明骨髓源性祖细胞[3](如CD11b+[4]和VEGFR1+[5]细胞)在转移起始中的作用。几种趋化因子,如SDF-1、TNF-α、TGF-β和VEGF-A影响不同细胞类型向转移前位点的募集,导致S100A8、S100A9、赖氨酸氧化酶(LOX)、纤维连接蛋白、MMP9和MMP2等特定分子在转移前生态位启动过程中的表达增加[6,7],这些分子是治疗靶点的真正候选者[8]。此外,肿瘤诱导的缺氧已被证明通过募集CD11b+/Ly6Cmed/Ly6G+细胞[9]和产生LOX来促进转移前生态位的形成[10]。最近,人们对肿瘤衍生的外泌体或微囊泡给予了大量关注,它们携带几乎所有必需的细胞大分子,并在种子(肿瘤细胞)到达之前,具有信号使肿瘤微环境中的细胞极化,并在远处器官中形成转移前生态位[11,12]。来自黑色素瘤的外泌体被证明可以在骨髓中培养前转移祖细胞[13]。肾癌来源的外泌体被发现可促进肺肿瘤转移的血管生成[14]。此外,对小鼠乳腺癌的研究表明,肿瘤来源的微泡利用骨桥蛋白动员来自骨髓的促血管生成细胞[15]。令人惊讶的是,外泌体通过独立于细胞的miRNA生物发生来促进肿瘤的发生和转移[16]。首先,肿瘤来源的外泌体具有促血管生成功能,帮助肿瘤建立肿瘤生长所需的脉管系统。例如,Yoon等人[17]研究了肿瘤分泌外泌体的促血管生成作用,通过ERK1/2和JNK信号通路在内皮细胞中激活Egr-1,并通过肿瘤细胞来源的细胞外囊泡促进内皮细胞迁移。另一方面,肿瘤来源的外泌体参与破坏血管完整性以转移。例如,miR-105是转移性乳腺癌细胞的特征性表达和分泌,据报道,miR-105通过外泌体靶向紧密连接蛋白ZO-1,是肿瘤细胞迁移的有效调节剂。肿瘤细胞分泌的外泌体将miR-105传递到内皮单层,有效地破坏紧密连接,从而破坏转移屏障的完整性[18]。虽然外泌体已经引起了人们的广泛关注,并被认为是癌症治疗的一个真正的靶点,但它们在肿瘤转移中的作用却很少被研究。此外,研究外泌体的技术和方法日益发展。肿瘤细胞外泌体有可能在任何免疫细胞或趋化因子之前被递送到操纵宿主环境的远端器官。然而,是什么引发肿瘤细胞向远处器官迁移,尚不清楚,即先有鸡还是先有蛋,需要进一步的研究。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信